Proteinuria as a Risk Marker for the Progression of Chronic Kidney Disease in Patients on Predialysis Care and the Role of Angiotensin-Converting Enzyme Inhibitor/Angiotensin II Receptor Blocker Treatment

Goeij, M.C.M. de; Liem, M.; Jager, D.J. de; Voormolen, N.; Sijpkens, Y.W.J.; Rotmans, J.I.; ... ; PREPARE-1 Study Grp (2012)

Article / Letter to editor

• Chronic kidney disease stages IV-V
• Predialysis care
• Proteinuria
• ACEi/ARBs
• Decline in renal function
• Renal replacement therapy

• All authors: Goeij, M.C.M. de; Liem, M.; Jager, D.J. de; Voormolen, N.; Sijpkens, Y.W.J.; Rotmans, J.I.; Boeschoten, E.W.; Dekker, F.W.; Grootendorst, D.C.; Halbesma, N.; PREPARE-1 Study Grp
• Date: 2012-12-31
• Journal: Nephron Clinical Practice
• Volume: 121
• Issue: 1-2
• Pages: C73 - C82
• DOI: doi:10.1159/000342392